90886-41-2 Usage
Description
(1-Methoxycyclohexyl)methanamine is a chemical compound with the molecular formula C8H17NO. It is an amine derivative that consists of a cyclohexyl group with a methoxy substituent at the 1-position and a methanamine group at the 2-position.
Uses
Used in Pharmaceutical Industry:
(1-Methoxycyclohexyl)methanamine is used as an intermediate in the synthesis of pharmaceuticals and organic compounds. It plays a crucial role in the development of new drugs and the modification of existing ones to improve their efficacy and safety.
Used in Neurological Disorders Treatment:
(1-Methoxycyclohexyl)methanamine has been investigated for its potential use in the treatment of neurological disorders. Its unique structure and properties make it a promising candidate for the development of therapeutic agents targeting various neurological conditions.
Used in Chemical Production:
(1-Methoxycyclohexyl)methanamine serves as a precursor in the production of chemicals, contributing to the synthesis of a wide range of chemical products with diverse applications.
Used as a Reagent in Chemical Reactions:
(1-Methoxycyclohexyl)methanamine is also known for its role as a reagent in chemical reactions, facilitating various processes and transformations in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 90886-41-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,8,8 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 90886-41:
(7*9)+(6*0)+(5*8)+(4*8)+(3*6)+(2*4)+(1*1)=162
162 % 10 = 2
So 90886-41-2 is a valid CAS Registry Number.
90886-41-2Relevant articles and documents
BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
-
Paragraph 0523; 0550; 0551, (2014/03/25)
The invention relates to benzamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, n and Y are as defined in the description, their preparation and their use as pharmaceutically active compounds.
